Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 2, 2016, Pages 746-758

  Cocho, Lidia ^a   Fernández, Itziar ^a,b   Calonge, Margarita ^a,b   Martínez, Verónica ^a   González García, María J ^a,b   Caballero, Dolores ^c   López Corral, Lucía ^c   García Vázquez, Carmen ^a   Vázquez, Lourdes ^c   Stern, Michael E ^d   Enríquez de Salamanca, Amalia ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d ALLERGAN INC   (United States)

Author keywords

Biomarker; Cytokine; Dry eye; Ocular chronic GVHD; Tears

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER; CCL11 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONJUNCTIVAL INTEGRITY; CONTROLLED STUDY; CORNEAL INTEGRITY; FEMALE; HUMAN; HYPEREMIA; LACRIMAL FLUID; MALE; MIDDLE AGED; OCULAR CHRONIC GRAFT VERSUS HOST DISEASE; OCULAR SURFACE INTEGRITY; OXFORD SCALE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SENSORY SYSTEM PARAMETERS; TEAR PRODUCTION; BIOLOGICAL MODEL; CASE CONTROL STUDY; COHORT ANALYSIS; DRY EYE; EYE DISEASES; GRAFT VERSUS HOST REACTION; METABOLISM; PATHOLOGY; PREDICTIVE VALUE;

ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL11; CHEMOKINES; COHORT STUDIES; CYTOKINES; DRY EYE SYNDROMES; EPIDERMAL GROWTH FACTOR; EYE DISEASES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; TEARS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959420936     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-18615     Document Type: Article

References (47)

1. Ogawa Y, Okamoto S, Wakui M, et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130.
2. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956.
3. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550-1561.
4. Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15:503-507.
5. Hessen M, Akpek E. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol. 2012;12:540-547.
6. Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389-401.
7. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5: 108-152.
8. Fuentes-Páez G, Herreras JM, Cordero Y, et al. Lack of concordance between dry eye syndrome questionnaires and diagnostic tests. Arch Soc Esp Oftalmol. 2011;86:3-7.
9. Paczesny S, Hakim FT, Pidala J, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol Blood Marrow Transplant. 2015;21:780-792.
10. Toubai T, Tanaka J, Paczesny S, et al. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)? Curr Stem Cell Res Ther. 2012;7: 229-239.
11. Berger M, Signorino E, Muraro M, et al. Monitoring of TNFR1, IL-2Ra, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in pediatric patients. Bone Marrow Transplant. 2013;48:1230-1236.
12. Cocho L, Fernández I, Calonge M, et al. Gene expression-based predictive models of graft versus host disease-associated dry eye. Invest Ophthalmol Vis Sci. 2015;56:4570-4581.
13. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj¨ogren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19: 201-211.
14. Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147: 198-205.
15. Enríquez de Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
16. Riemens A, Stoyanova E, Rothova A, et al. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol Vis. 2012;18:797- 802.
17. Jung JW, Han SJ, Song MK, et al. Tear cytokines as biomarkers for chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:2079-2085.
18. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113:273-278.
19. Curtis LM, Datiles MB III, Steinberg SM, et al. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. Haematologica. 2015;100:1228-1236.
20. Tesón M, González-García MJ, López-Miguel A, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci. 2013;54: 2093-2099.
21. López-Miguel A, Tesón M, Martín-Montañez V, et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol. 2014; 157:788-798.
22. López-Miguel A, Tesón M, Martín-Montañez V, et al. Clinical and molecular inflammatory response in Sj¨ogren syndromeassociated dry eye patients under desiccating stress. Am J Ophthalmol. 2016;161:133-141, e2.
23. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
24. Efron N, Morgan PB, Jagpal R. Validation of computer morphs for grading contact lens complications. Ophthalmic Physiol Opt. 2002;22:341-349.
25. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
26. Helsel, DR, Cohn TA. Estimation of descriptive statistics for multiply-censored water-quality data. Water Resour Res. 1988; 24:1997-2004.
27. Lee L. NADA: Nondetects and data analysis for environmental data. R package version 1.5-6. 2013. Available at: https://cran. r-project.org/web/packages/NADA/index.html. Accessed January 2014.
28. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and Sþ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
29. Weng Y, Siciliano SJ, Waldburger KE, et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998;273:18288- 18291.
30. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, et al. Leukocyte migration and graft-versus host disease. Blood. 2005;105: 4191-4199.
31. Duffner U, Lu B, Hildebrandt GC, et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003;31: 897-902.
32. Piper KP, Horlock C, Curnow SJ, et al. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood. 2007;110:3827-3832.
33. Westekemper H, Meller S, Citak S, et al. Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant. 2010;45:1340-1346.
34. Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023-1027.
35. Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sj¨ogren syndrome dry eye patients and non-Sj¨ogren syndrome dry eye patients. Am J Ophthalmol. 2013;156:247-253.
36. Garlanda C, Riva F, Bonavita E, et al. Negative regulatory receptors of the IL-1 family. Semin Immunol. 2013;25:408- 415.
37. Cullup H, Stark G. Interleukin-1 polymorphisms and graft-vshost disease. Leuk Lymphoma. 2005;46:517-523.
38. Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia. 2003;17: 1150-1156.
39. Levine JE, Logan BR, Wu J, et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood. 2012;119:3854-3860.
40. Weber M, Stein P, Pr¨ufer S, et al. Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease. Eur J Immunol. 2014;44:1857-1865.
41. Sakata N, Yasui M, Okamura T, et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant. 2001;27:1153-1161.
42. Fujii N, Hiraki A, Aoe K, et al. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array. Int J Mol Med. 2006;17:881-885.
43. Enríquez-de-Salamanca A, Calonge M. Cytokines and chemokines in immune-based ocular surface inflammation. Expert Rev Clin Immunol. 2008;4:457-467.
44. Moons KG, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691-698.
45. Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:340-349.
46. Chen YB, Cutler CS. Biomarkers for acute GVHD: can we predict the unpredictable? Bone Marrow Transplant. 2013; 48:755-760.
47. Von Thun Und Hohenstein-Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res. 2013;117:126-137.